CDH17 and neoplasm: It is also possible that CDH17 contributes more strongly to functional tumour behaviour (e.g., Wnt activation, progression, EMT, stemness) than to baseline stage or sex-stratified progression, underscoring the need for larger clinical studies to clarify these associations.